Follow
Jessica Ann Finn
Jessica Ann Finn
Senior Scientist, Protein Engineering at Atreca, Inc.
Verified email at atreca.com
Title
Cited by
Cited by
Year
High frequency of shared clonotypes in human B cell receptor repertoires
C Soto, RG Bombardi, A Branchizio, N Kose, P Matta, AM Sevy, ...
Nature 566 (7744), 398-402, 2019
2682019
A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface
S Bangaru, S Lang, M Schotsaert, HA Vanderven, X Zhu, N Kose, ...
Cell 177 (5), 1136-1152. e18, 2019
2002019
Protocols for molecular modeling with Rosetta3 and RosettaScripts
BJ Bender, A Cisneros III, AM Duran, JA Finn, D Fu, AD Lokits, BK Mueller, ...
Biochemistry 55 (34), 4748-4763, 2016
1942016
Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
JJ Mousa, MF Sauer, AM Sevy, JA Finn, JT Bates, G Alvarado, HG King, ...
Proceedings of the National Academy of Sciences 113 (44), E6849-E6858, 2016
472016
Tissue-specific expressed antibody variable gene repertoires
BS Briney, JR Willis, JA Finn, BA McKinney, JE Crowe Jr
PLoS One 9 (6), e100839, 2014
402014
Structural diversity of ultralong CDRH3s in seven bovine antibody heavy chains
J Dong, JA Finn, PA Larsen, TPL Smith, JE Crowe Jr
Frontiers in immunology 10, 558, 2019
372019
Impact of new sequencing technologies on studies of the human B cell repertoire
JA Finn, JE Crowe Jr
Current opinion in immunology 25 (5), 613-618, 2013
332013
Improving loop modeling of the antibody complementarity-determining region 3 using knowledge-based restraints
JA Finn, J Koehler Leman, JR Willis, A Cisneros III, JE Crowe Jr, J Meiler
PloS one 11 (5), e0154811, 2016
282016
Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design
CT Schoeder, S Schmitz, J Adolf-Bryfogle, AM Sevy, JA Finn, MF Sauer, ...
Biochemistry 60 (11), 825-846, 2021
272021
Recognition of influenza H3N2 variant virus by human neutralizing antibodies
S Bangaru, T Nieusma, N Kose, NJ Thornburg, JA Finn, BS Kaplan, ...
JCI insight 1 (10), 2016
262016
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization
JR Willis, JA Finn, B Briney, G Sapparapu, V Singh, H King, ...
PNAS, 2016
252016
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
SJ Zost, J Dong, IM Gilchuk, P Gilchuk, NJ Thornburg, S Bangaru, N Kose, ...
The Journal of Clinical Investigation, 2021
242021
PyIR: a scalable wrapper for processing billions of immunoglobulin and T cell receptor sequences using IgBLAST
C Soto, JA Finn, JR Willis, SB Day, RS Sinkovits, T Jones, S Schmitz, ...
BMC bioinformatics 21 (1), 1-7, 2020
212020
Identification of structurally related antibodies in antibody sequence databases using rosetta-derived position-specific scoring
JA Finn, J Dong, AM Sevy, E Parrish, I Gilchuk, R Nargi, M Scarlett-Jones, ...
Structure 28 (10), 1124-1130. e5, 2020
102020
Antibodies that bind tumor tissue for diagnosis and therapy
J DeFalco, DE Emerling, J Finn, NM Greenberg, V Huang, SM Lippow, ...
US Patent App. 17/935,152, 2023
2023
Discovery and pre-clinical development of a novel and differentiated EphA2-targeted antibody in multiple bispecific formats
M Bhatti, M Weiss, A Haltom, J Finn, A Gai, A Ye, D Zhang, C Czupalla, ...
Journal for Immunotherapy of Cancer 10, A1238-A1238, 2022
2022
EphA2 antibodies
A Scholz, N Vad, MS Weiss, YE Anne, D Zhang, IT Aydin, MM Bhatti, ...
US Patent App. 17/687,558, 2022
2022
Antibodies that bind tumor tissue for diagnosis and therapy
J DeFalco, DE Emerling, J Finn, NM Greenberg, V Huang, SM Lippow, ...
US Patent App. 16/792,115, 2020
2020
Tissue-Specific Expressed Antibody Variable Gene Repertoires (vol 9, e100839, 2014)
BS Briney, JR Willis, JA Finn, BA McKinney, JE Crowe Jr
PLOS ONE 15 (1), 2020
2020
Correction: Tissue-Specific Expressed Antibody Variable Gene Repertoires
BS Briney, JR Willis, JA Finn, BA McKinney, JE Crowe Jr
Plos one 15 (1), e0228412, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20